Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a note issued to investors on Wednesday, TheStreetRatingsTable reports. A number of other brokerages have also recently weighed in on IONS. Guggenheim started coverage on shares of Ionis Pharmaceuticals in a research note […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) – Investment analysts at Oppenheimer decreased their Q1 2022 earnings per share estimates for shares of Ionis Pharmaceuticals in a research note issued to investors on Monday, April 18th. Oppenheimer analyst K. Degeeter now anticipates that the company will post earnings of ($0.75) per share for the quarter, […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) had its price objective cut by SVB Leerink from $29.00 to $26.00 in a report issued on Friday morning, MarketBeat.com reports. They currently have a market perform rating on the stock. Other research analysts also recently issued reports about the company. BMO Capital Markets initiated coverage on Ionis Pharmaceuticals […]
AE Wealth Management LLC bought a new position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 26,085 shares of the company’s stock, valued at approximately $794,000. Several other institutional investors and […]
IFP Advisors Inc raised its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 55.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,673 shares of the company’s stock after buying an additional 953 shares during the period. […]